First published March 21, 2016 - More info
Yunzhou Dong, Hao Wu, H.N. Ashiqur Rahman, Yanjun Liu, Satish Pasula, Kandice L. Tessneer, Xiaofeng Cai, Xiaolei Liu, Baojun Chang, John McManus, Scott Hahn, Jiali Dong, Megan L. Brophy, Lili Yu, Kai Song, Robert Silasi-Mansat, Debra Saunders, Charity Njoku, Hoogeun Song, Padmaja Mehta-D’Souza, Rheal Towner, Florea Lupu, Rodger P. McEver, Lijun Xia, Derek Boerboom, R. Sathish Srinivasan, Hong Chen
Original citation: J Clin Invest. 2015;125(12):4349–4364. doi:10.1172/JCI80349.
Citation for this corrigendum: J Clin Invest. 126(4):1607. doi:10.1172/JCI87344.
Hao Wu’s designation as co–first author was inadvertently omitted from the manuscript, and some of his work was omitted from the Author Contributions section. The correct authorship note and sentences from the Author Contributions section are below.
Authorship note: Y. Dong and H. Wu are co–first authors.
YD, HW, and HC designed, analyzed, and interpreted the data.
HW performed the molecular modeling work to identify key residues in the Epsin 1 UIM and in VEGFR2.
The authors regret the error.